发明授权
US07507729B2 Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives
失效
取代的咪唑并[1,5-a] [1,2,4]三唑并[1,5-d] [1,4]苯并二氮杂衍生物
- 专利标题: Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives
- 专利标题(中): 取代的咪唑并[1,5-a] [1,2,4]三唑并[1,5-d] [1,4]苯并二氮杂衍生物
-
申请号: US11542944申请日: 2006-10-04
-
公开(公告)号: US07507729B2公开(公告)日: 2009-03-24
- 发明人: Bernd Buettelmann , Henner Knust , Andrew Thomas
- 申请人: Bernd Buettelmann , Henner Knust , Andrew Thomas
- 申请人地址: US NJ Nutley
- 专利权人: Hoffmann-La Roche Inc.
- 当前专利权人: Hoffmann-La Roche Inc.
- 当前专利权人地址: US NJ Nutley
- 代理商 George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
- 优先权: EP05109446 20051011
- 主分类号: A61P25/28
- IPC分类号: A61P25/28 ; A61K31/55 ; C07D243/00
摘要:
The present invention is concerned with substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formula wherein the definition of substituents is described in the claims. This class of compounds shows high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as a cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
公开/授权文献
信息查询